Tatva Chintan Pharma Chem Limited
NSE: TATVA | Information Technology
Market Fundamentals
Stock Intelligence & News
Tatva Chintan Pharma Chem Ltd (543321)
Intimation of Closure of Trading Window
Read Full Analysis →Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Tatva Chintan Pharma Chem Ltd (543321)
Newspaper Advertisement - Disclosure under Regulation 30, 44 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ("SEBI Listing Regulations") - (Post Dispatch)
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Tatva Chintan Pharma Chem Ltd (543321)
Intimation of Record Date, Book Closure and Cut-Off Date pursuant to Regulation 42 and 44 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Read Full Analysis →Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Sep-2026. |SUBJECT: Record Date
Read Full Analysis →Tatva Chintan Pharma Chem Ltd (543321)
Pursuant to Regulation 34(2)(f) of the SEBI Listing Regulations, we are submitting herewith the Business Responsibility and Sustainability Report (BRSR") for FY 2025-26 which forms part of the Annual Report FY 2025-26.
Read Full Analysis →Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding ' Business Responsibility and Sustainability Report for the FY 2025-26'. |SUBJECT: Updates
Read Full Analysis →Tatva Chintan Pharma Chem Ltd (543321)
Pursuant to Regulation 34(1) of the SEBI Listing Regulations, please find enclosed herewith the Annual Report of the Company along with the Notice of the 30th Annual General Meeting ('AGM') and other Statutory Reports for the Financial Year 2025-26. The same is also being sent through electronic mode to those members whose email addresses are registered with the Company/Registrar and Share Transfer Agent ('RTA')/Depositories. Further, pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter containing the web-link and QR code, along with the exact path, for accessing the Annual Report, is being sent to those Members whose email addresses are not registered with the Company/RTA/Depositories. Further, the 30th AGM of the Company will be held on Friday, 25 September 2026 at 04:00 p.m. (IST) through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM"). The Annual Report of the Company is also available on the website of the Company at www.tatvachintan.com.
Read Full Analysis →Tatva Chintan Pharma Chem Ltd (543321)
Notice of the 30th AGM of the Members of the Company scheduled to be held on Friday, 25 September 2026 at 4:00 p.m. (IST) through Video Conferencing (''VC") / Other Audio Visual Means ("OAVN")
Read Full Analysis →Get instant alerts when TATVA breaks news
Join investors who track Tatva Chintan Pharma Chem Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for TATVA?
TATVA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Tatva Chintan Pharma Chem Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding TATVA to your custom watchlist.